LOXO-292

• Description:

  LOXO-292 (Selpercatinib, LOXO 292, LOXO292) is a potent, selective, orally available RET kinase inhibitor with potential antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  525.613

• Molecular Formula:

  C29H31N7O3

• Notes:

  Research use only, not for human use.

• Receptor:

  C-RET

• CAS Number:

  2152628-33-4